Follow The Filings

ASPI ASP Isotopes

ASP Isotopes earnings company data as of 4:00 PM ET 11/22

  • 1 of 2 EPS beats

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 16 Nov EPS -0.13 -0.21 Miss
Rev — — —
FY2026 Q2 14 Aug EPS -0.39 -0.27 Beat
Rev — $3.6M —

Insider trades

Open-market buys and sales by ASPI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ASPI insider trades
  • $62K bought by 1 insider
  • $1.9M sold by 4 insiders outside a trading plan
  • $704K sold by 3 insiders under 10b5-1 plans
  1. Robert John Andrew Ryan Director
    Buy
    $40K 15,000 shares at $2.68 +2.3% to stake
    Traded Sep 30 Filed Oct 1
  2. Robert John Andrew Ryan Director
    Buy
    $22K 8,000 shares at $2.70 +1.2% to stake
    Traded Sep 28 Filed Sep 30
  3. Robert Ainscow COO
    Planned sale
    $98K 25,000 shares at $3.91 1.1% of stake
    Traded Sep 2 Filed Sep 4
  4. Donald George Ainscow EVP, Gen Counsel, Secretary
    Sale
    $614K 100,000 shares at $6.14 11% of stake
    Traded Jun 30 Filed Jul 2
  5. Todd Wider Director
    Sale
    $619K 100,000 shares at $6.19 13% of stake
    Traded Jun 29–30 Filed Jul 1
  6. Michael Gorley Director
    Sale
    $188K 30,000 shares at $6.27 25% of stake
    Traded Jun 30 Filed Jul 1
  7. Duncan Moore Director
    Planned sale
    $61K 11,642 shares at $5.21 1.1% of stake
    Traded Apr 16 Filed Apr 17
  8. Robert Ainscow COO
    Planned sale
    $113K 25,000 shares at $4.51 1.6% of stake
    Traded Mar 6 Filed Apr 13
  9. Heather Kiessling CFO
    Sale
    $464K 80,000 shares at $5.80 9.8% of stake
    Traded Dec 18, 2025 Filed Dec 29, 2025
  10. Robert Ainscow CEO
    Planned sale
    $144K 25,000 shares at $5.77 1.6% of stake
    Traded Nov 25, 2025 Filed Nov 28, 2025
  11. Paul Elliot Mann Executive Officer
    Planned sale
    $288K 50,000 shares at $5.77 0.6% of stake
    Traded Nov 25, 2025 Filed Nov 28, 2025

Also filed in the last 12 months, not counted as buying or selling: 19 sales to cover taxes and 9 stock grants.

SEC filings

Recent issuer filings from EDGAR, 23 shown.

Filed Form Detail Links
10-Q
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 7.01,9.01
8-K 7.01,9.01
SCHEDULE 13D —
8-K 7.01
8-K 7.01,9.01
8-K 7.01,9.01
8-K 1.01,1.02,2.03,9.01
8-K 7.01,9.01
10-Q
8-K 7.01,9.01
8-K 7.01,9.01
8-K 2.02,7.01,9.01
8-K 7.01,9.01
8-K 7.01,9.01
8-K 7.01,9.01
8-K 1.01,3.02,7.01,9.01
8-K 8.01,9.01
8-K 7.01,9.01
8-K 1.01,3.02,7.01,8.01,9.01
8-K 7.01,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf